| Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia. | |
| | |
MedLine Citation:
|
PMID: 17426083 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
CONTEXT: Recent reports have demonstrated that soluble endoglin (sEng), an antiangiogenic protein thought to impair TGF-beta binding to receptors, and soluble vascular endothelial growth factor receptor (sVEGFR)-1 play important roles in the pathophysiology of preeclampsia (PE). Moreover, insulin resistance, which is greatly influenced by adipocytokines, characterizes PE. OBJECTIVES: We examined possible links between sEng, VEGF, sVEGFR, and adipocytokines in the pathophysiology of PE. STUDY DESIGN: We performed a cross-sectional study in 30 PE patients and controls matched for gestational age and body mass index. Blood samples were collected soon after disease onset. We measured serum concentrations of leptin, adiponectin, sEng, VEGF, placental growth factor (PlGF), and sVEGFR [soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble fetal liver kinase 1 (sFlk-1)], and examined the placental protein content of sEng and sFlt-1. RESULTS: sEng concentrations in PE patients (60.9 +/- 28.8 ng/ml) were significantly higher than those in controls (11.2 +/- 4.4 ng/ml). There was a significant correlation between sEng and sFlt-1 or PlGF. Moreover, there were significant differences in mean blood pressure between the high and low sEng groups, and in proteinuria between the high and low sFlt-1 groups, and significant differences in placental sEng and sFlt-1 contents between patients with and without severe hypertension or proteinuria. sEng was also correlated positively with adiponectin levels and negatively with the leptin to adiponectin ratio. CONCLUSIONS: Along with sFlt-1 and PlGF, sEng might play a role in the pathophysiology of PE, especially in elevating blood pressure, while the association with hypoadiponectinemia and the high leptin to adiponectin ratio in pregnancy seem to be risk factors for PE. |
| | |
Authors:
|
Hisashi Masuyama; Hideki Nakatsukasa; Norio Takamoto; Yuji Hiramatsu |
Related Documents
:
|
12950033 - Evolution of placental specializations in viviparous african and south american lizards. 11910513 - Congenital nephrosis of the finnish type: overview of placental pathology and literatur... 22613613 - Efficacy of local aspiration in the conservative treatment of live interstitial pregnan... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2007-04-10 |
Journal Detail:
|
Title: The Journal of clinical endocrinology and metabolism Volume: 92 ISSN: 0021-972X ISO Abbreviation: J. Clin. Endocrinol. Metab. Publication Date: 2007 Jul |
Date Detail:
|
Created Date: 2007-07-09 Completed Date: 2007-08-28 Revised Date: 2009-11-25 |
Medline Journal Info:
|
Nlm Unique ID: 0375362 Medline TA: J Clin Endocrinol Metab Country: United States |
Other Details:
|
Languages: eng Pagination: 2672-9 Citation Subset: AIM; IM |
Affiliation:
|
Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Shikata, Okayama 700-8558, Japan. masuyama@cc.okayama-u.ac.jp |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adiponectin
/
blood* Adult Antigens, CD / blood* Blood Pressure Female Humans Leptin / blood* Placenta / metabolism Pre-Eclampsia / epidemiology, metabolism* Pregnancy Pregnancy Proteins / blood Receptors, Cell Surface / blood* Risk Factors Severity of Illness Index Solubility Vascular Endothelial Growth Factor Receptor-1 / blood* Vascular Endothelial Growth Factor Receptor-2 / blood |
| Chemical | |
Reg. No./Substance:
|
0/Adiponectin; 0/Antigens, CD; 0/ENG protein, human; 0/Leptin; 0/Pregnancy Proteins; 0/Receptors, Cell Surface; 144589-93-5/placenta growth factor; EC 2.7.10.1/Vascular Endothelial Growth Factor Receptor-1; EC 2.7.10.1/Vascular Endothelial Growth Factor Receptor-2 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restricti...
Next Document: High prevalence and mutual exclusivity of genetic alterations in the phosphatidylinositol-3-kinase/a...